HKD 1.1
(-0.9%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 135.69 Million CNY | 76302.03% |
2022 | 177.6 Thousand CNY | 20.41% |
2021 | 147.5 Thousand CNY | 9.34% |
2020 | 134.9 Thousand CNY | -94.16% |
2019 | 2.31 Million CNY | 10404.55% |
2018 | 22 Thousand CNY | -99.93% |
2017 | 30 Million CNY | 0.0% |
2016 | - CNY | 0.0% |
2015 | - CNY | 0.0% |
2014 | - CNY | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 FY | 135.69 Million CNY | 76302.03% |
2023 Q2 | 214.3 Thousand CNY | 20.66% |
2023 Q4 | 135.69 Million CNY | 63217.78% |
2022 Q4 | 177.6 Thousand CNY | 4.29% |
2022 FY | 177.6 Thousand CNY | 20.41% |
2022 Q2 | 170.3 Thousand CNY | 15.46% |
2021 Q2 | 132.1 Thousand CNY | -2.08% |
2021 FY | 147.5 Thousand CNY | 9.34% |
2021 Q4 | 147.5 Thousand CNY | 11.66% |
2020 Q2 | 98.5 Thousand CNY | -95.74% |
2020 Q4 | 134.9 Thousand CNY | 36.95% |
2020 FY | 134.9 Thousand CNY | -94.16% |
2019 FY | 2.31 Million CNY | 10404.55% |
2019 Q4 | 2.31 Million CNY | 0.0% |
2018 FY | 22 Thousand CNY | -99.93% |
2017 Q2 | - CNY | 0.0% |
2017 Q4 | 30 Million CNY | 0.0% |
2017 FY | 30 Million CNY | 0.0% |
2016 FY | - CNY | 0.0% |
2016 Q4 | - CNY | 0.0% |
2015 FY | - CNY | 0.0% |
2014 FY | - CNY | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | 30.61 Million HKD | -343.258% |
CK Life Sciences Int'l., (Holdings) Inc. | 4.27 Billion HKD | 96.824% |